Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8434129rdf:typepubmed:Citationlld:pubmed
pubmed-article:8434129lifeskim:mentionsumls-concept:C0999699lld:lifeskim
pubmed-article:8434129lifeskim:mentionsumls-concept:C0040578lld:lifeskim
pubmed-article:8434129lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:8434129lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:8434129lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:8434129lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:8434129lifeskim:mentionsumls-concept:C0205464lld:lifeskim
pubmed-article:8434129lifeskim:mentionsumls-concept:C1709059lld:lifeskim
pubmed-article:8434129lifeskim:mentionsumls-concept:C0066447lld:lifeskim
pubmed-article:8434129pubmed:issue1lld:pubmed
pubmed-article:8434129pubmed:dateCreated1993-3-17lld:pubmed
pubmed-article:8434129pubmed:abstractTextThe spasmogenic activity of methylxanthines was evaluated in guinea-pig isolated trachea treated with indomethacin (2.8 microM) and cooled to 20 degrees C. The contraction elicited by caffeine or theophylline (10 mM) was reduced in the presence of ouabain (10 microM), amiloride (100 microM), staurosporine (1 microM), H-7 (50 microM), polymyxin B (500 microM), K(+)-free solution, low Na+ (25 mM) medium or Ca(2+)-free (EGTA 0.1 mM) solution but was unaltered in the presence of verapamil (10 microM) or vanadate (10-100 microM). These results suggest that tracheal spasm to methylxanthines predominantly involves Ca2+ release from intracellular stores with a minor component due to extracellular Ca2+ entry through verapamil-insensitive pathways. A Na+/Ca2+ exchange process and the activation of protein kinase C may be also involved.lld:pubmed
pubmed-article:8434129pubmed:languageenglld:pubmed
pubmed-article:8434129pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8434129pubmed:citationSubsetIMlld:pubmed
pubmed-article:8434129pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8434129pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8434129pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8434129pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8434129pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8434129pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8434129pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8434129pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8434129pubmed:statusMEDLINElld:pubmed
pubmed-article:8434129pubmed:monthJanlld:pubmed
pubmed-article:8434129pubmed:issn0034-5164lld:pubmed
pubmed-article:8434129pubmed:authorpubmed-author:RothR ARAJrlld:pubmed
pubmed-article:8434129pubmed:authorpubmed-author:AntonMMlld:pubmed
pubmed-article:8434129pubmed:authorpubmed-author:MorcilloE JEJlld:pubmed
pubmed-article:8434129pubmed:authorpubmed-author:CortijoJJlld:pubmed
pubmed-article:8434129pubmed:authorpubmed-author:VillagrasaVVlld:pubmed
pubmed-article:8434129pubmed:issnTypePrintlld:pubmed
pubmed-article:8434129pubmed:volume79lld:pubmed
pubmed-article:8434129pubmed:ownerNLMlld:pubmed
pubmed-article:8434129pubmed:authorsCompleteYlld:pubmed
pubmed-article:8434129pubmed:pagination125-8lld:pubmed
pubmed-article:8434129pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:8434129pubmed:meshHeadingpubmed-meshheading:8434129-...lld:pubmed
pubmed-article:8434129pubmed:meshHeadingpubmed-meshheading:8434129-...lld:pubmed
pubmed-article:8434129pubmed:meshHeadingpubmed-meshheading:8434129-...lld:pubmed
pubmed-article:8434129pubmed:meshHeadingpubmed-meshheading:8434129-...lld:pubmed
pubmed-article:8434129pubmed:meshHeadingpubmed-meshheading:8434129-...lld:pubmed
pubmed-article:8434129pubmed:meshHeadingpubmed-meshheading:8434129-...lld:pubmed
pubmed-article:8434129pubmed:meshHeadingpubmed-meshheading:8434129-...lld:pubmed
pubmed-article:8434129pubmed:meshHeadingpubmed-meshheading:8434129-...lld:pubmed
pubmed-article:8434129pubmed:meshHeadingpubmed-meshheading:8434129-...lld:pubmed
pubmed-article:8434129pubmed:meshHeadingpubmed-meshheading:8434129-...lld:pubmed
pubmed-article:8434129pubmed:meshHeadingpubmed-meshheading:8434129-...lld:pubmed
pubmed-article:8434129pubmed:meshHeadingpubmed-meshheading:8434129-...lld:pubmed
pubmed-article:8434129pubmed:meshHeadingpubmed-meshheading:8434129-...lld:pubmed
pubmed-article:8434129pubmed:meshHeadingpubmed-meshheading:8434129-...lld:pubmed
pubmed-article:8434129pubmed:meshHeadingpubmed-meshheading:8434129-...lld:pubmed
pubmed-article:8434129pubmed:meshHeadingpubmed-meshheading:8434129-...lld:pubmed
pubmed-article:8434129pubmed:meshHeadingpubmed-meshheading:8434129-...lld:pubmed
pubmed-article:8434129pubmed:year1993lld:pubmed
pubmed-article:8434129pubmed:articleTitlePharmacological modulation of the spasmogenic response to methylxanthines in guinea-pig trachea.lld:pubmed
pubmed-article:8434129pubmed:affiliationDepartament of Pharmacology, Faculty of Medicine, University of Valencia, Spain.lld:pubmed
pubmed-article:8434129pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8434129pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:8434129pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed